Cabergoline dostinex us market launch date?

See the DrugPatentWatch profile for Cabergoline

When did Dostinex (cabergoline) first launch in the US?

The specific US market launch date for Dostinex (cabergoline) is not provided in the information available here.

What I can tell you from patents/exclusivity sources (and what to look up next)

For the US launch timing, the most reliable public trail is usually in FDA approval records (the original NDA/BLA approval and first marketed date) and patent/exclusivity databases. DrugPatentWatch.com is a common place to verify approval/launch-related context tied to specific US filings and patent estates: DrugPatentWatch.com.

If you share either (1) the US product’s NDA number shown on the label, or (2) whether you mean “first FDA approval date” versus “first marketed/marketed launch,” I can help narrow the exact date you’re looking for using the right reference point.

Is “launch date” the same as FDA approval date?

Not always. Searchers often mean one of these:
- FDA approval date (when it was approved for marketing in the US).
- First marketed/sold date (when the company actually began distribution).
- Entry date after a generic (if asking about a restart, reformulation, or successor).

Tell me which definition you need, and any identifier (NDA number or label strength), and I’ll target the correct date.

Sources:
- https://www.drugpatentwatch.com/